Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warfarin for prevention of permacath failure in hemodialysis patients
IRCT20200516047461N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of warfarin and heparin in chronic kidney disease (CKD) (2 arms), sponsored by Isfahan University of Medical Sciences. Started Jan 2020; status: completed.
02
Drugs
warfarinheparin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT20200516047461N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200516047461N1.